Trade TCRT stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Alaunos Therapeutics, Inc. (TCRT) is trading at US$2.63, up 20.64% today as of Oct 16, 16:00 EDT. The company has a market capitalisation of US$4.47M. Over the past 52 weeks, TCRT has traded between US$0.72 and US$4.50. On Syfe you can trade TCRT with $0 commission and add it to your watchlist.
| Previous close | US$2.18 |
|---|---|
| Market cap | US$4.47M |
| 52-week range | US$0.72 – US$4.50 |
| Volume | 31.51M |
| Exchange | US |
Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc. is a biopharmaceutical company and clinical-stage oncology-focused cell therapy company, which engages in the development of adoptive TCR engineered T-cell therapies, or TCR-T, designed to treat multiple solid tumor types in large cancer patient populations with unmet clinical needs. Its pipeline includes Library TCR-T cell and mblL-15 TCR-T cell Therapy. The company was founded in 2003 and is headquartered in Fort Lauderdale, FL.
Year: 2005
Alaunos Therapeutics, Inc. (TCRT) stock is trading at US$2.63, +20.64% from the previous close of US$2.18.
The market cap for Alaunos Therapeutics, Inc. (TCRT) stock is approximately US$4.47M.
The 52-week high for Alaunos Therapeutics, Inc. (TCRT) stock is US$4.50.
The 52-week low for Alaunos Therapeutics, Inc. (TCRT) stock is US$0.72.
Alaunos Therapeutics, Inc. (TCRT) does not currently pay a dividend.
Stay on top of TCRT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
